SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-010725
Filing Date
2024-03-13
Accepted
2024-03-12 21:14:11
Documents
114
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cpix-20231231.htm   iXBRL 10-K 1764894
2 EX-4.11 a2023q4exhibit411.htm EX-4.11 28978
3 EX-10.11 ex-1011ajkazimix202310k.htm EX-10.11 39933
4 EX-10.12 ex-1012jimhermanx202310k.htm EX-10.12 40394
5 EX-10.13 ex-1013toddanthonyx202310k.htm EX-10.13 39816
6 EX-10.14 ex-1014chrisbittermanx2023.htm EX-10.14 39915
7 EX-10.15 ex-1015johnhammx202310k.htm EX-10.15 39795
8 EX-23.1 a2023-10kxex231consentofcri.htm EX-23.1 2130
9 EX-23.2 a2023-xex232consentofforvi.htm EX-23.2 2260
10 EX-31.1 a2023-10kxexhibit311.htm EX-31.1 12788
11 EX-31.2 a2023-10kxexhibit312.htm EX-31.2 12260
12 EX-32.1 a2023-10kxexhibit321.htm EX-32.1 6520
13 EX-97.1 a2023-xex971compensationre.htm EX-97.1 32408
19 cpix-20231231_g1.jpg GRAPHIC 109359
  Complete submission text file 0001628280-24-010725.txt   9572839

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20231231.xsd EX-101.SCH 74585
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20231231_cal.xml EX-101.CAL 90810
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20231231_def.xml EX-101.DEF 281825
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20231231_lab.xml EX-101.LAB 817134
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20231231_pre.xml EX-101.PRE 565787
116 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20231231_htm.xml XML 1132598
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 24744328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)